{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:09:52Z","timestamp":1791641392325,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10067-024-07129-6","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T23:04:07Z","timestamp":1726009447000},"page":"3477-3485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of HIF1A gene polymorphisms with serum uric acid and HIF-1\u03b1 levels in monosodium urate crystal-induced arthritis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-2862","authenticated-orcid":false,"given":"Javier","family":"Fern\u00e1ndez-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-7424","authenticated-orcid":false,"given":"Ambar","family":"L\u00f3pez-Macay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-3454","authenticated-orcid":false,"given":"Yessica","family":"Zamudio-Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-0227","authenticated-orcid":false,"given":"Karina","family":"Mart\u00ednez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"7129_CR1","doi-asserted-by":"publisher","first-page":"1759720X2211140","DOI":"10.1177\/1759720X221114098","volume":"14","author":"F Sivera","year":"2022","unstructured":"Sivera F, Andres M, Dalbeth N (2022) A glance into the future of gout. Ther Adv Musculoskelet Dis 14:1759720X221114098. https:\/\/doi.org\/10.1177\/1759720X221114098","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7129_CR2","doi-asserted-by":"publisher","first-page":"861399","DOI":"10.3389\/fphar.2022.861399","volume":"13","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kim HS, Lee JH, Yang G, Kim HJ (2022) Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout. Front Pharmacol 13:861399. https:\/\/doi.org\/10.3389\/fphar.2022.861399","journal-title":"Front Pharmacol"},{"key":"7129_CR3","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","volume":"2","author":"V Kl\u00fcck","year":"2020","unstructured":"Kl\u00fcck V, Jansen TLTA, Janssen M, Comarniceanu A, Efd\u00e9 M, Tengesdal IW, Schraa K, Cleophas MCP, Scribner CL, Skouras DB, Marchetti C, Dinarello CA, Joosten LAB (2020) Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2:e270\u2013e280. https:\/\/doi.org\/10.1016\/s2665-9913(20)30065-5","journal-title":"Lancet Rheumatol"},{"key":"7129_CR4","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.berh.2021.101723","volume":"35","author":"A Danve","year":"2021","unstructured":"Danve A, Sehra ST, Neogi T (2021) Role of diet in hyperuricemia and gout. Best Pract Res Clin Rheumatol 35:101723. https:\/\/doi.org\/10.1016\/j.berh.2021.101723","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7129_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000355405","volume":"3","author":"K Chaudhary","year":"2013","unstructured":"Chaudhary K, Malhotra K, Sowers J, Aroor A (2013) Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med 3:208\u2013220. https:\/\/doi.org\/10.1159\/000355405","journal-title":"Cardiorenal Med"},{"key":"7129_CR6","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1073\/pnas.89.8.3362","volume":"89","author":"LS Terada","year":"1992","unstructured":"Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, Repine JE (1992) Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci U S A 89:3362\u20133366. https:\/\/doi.org\/10.1073\/pnas.89.8.3362","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7129_CR7","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.2174\/138161205774913255","volume":"11","author":"GK Glantzounis","year":"2005","unstructured":"Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145\u20134151. https:\/\/doi.org\/10.2174\/138161205774913255","journal-title":"Curr Pharm Des"},{"key":"7129_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2005.11.008","volume":"40","author":"EE Kelley","year":"2006","unstructured":"Kelley EE, Hock T, Khoo NK, Richardson GR, Johnson KK, Powell PC, Giles GI, Agarwal A, Lancaster JR Jr, Tarpey MM (2006) Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic Biol Med 40:952\u2013959. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.11.008","journal-title":"Free Radic Biol Med"},{"key":"7129_CR9","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1381612825666190408122557","volume":"25","author":"S Zhang","year":"2019","unstructured":"Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D (2019) Hyperuricemia and Cardiovascular Disease. Curr Pharm Des 25:700\u2013709. https:\/\/doi.org\/10.2174\/1381612825666190408122557","journal-title":"Curr Pharm Des"},{"key":"7129_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF (2012) Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed) 17:656\u2013669. https:\/\/doi.org\/10.2741\/3950","journal-title":"Front Biosci (Landmark Ed)"},{"key":"7129_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.abb.2019.06.010","volume":"670","author":"Wu Mian","year":"2019","unstructured":"Mian Wu (2019) Zhang M, Ma Y, Liu F, Chen S, Lu J, Chen H (2019) Chaetocin attenuates gout in mice through inhibiting HIF-1\u03b1 and NLRP3 inflammasome-dependent IL-1\u03b2 secretion in macrophages. Arch Biochem Biophys 670:94\u2013103. https:\/\/doi.org\/10.1016\/j.abb.2019.06.010","journal-title":"Arch Biochem Biophys"},{"key":"7129_CR12","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92:5510\u20135514. https:\/\/doi.org\/10.1073\/pnas.92.12.5510","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7129_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ki.1997.77","volume":"51","author":"GL Semenza","year":"1997","unstructured":"Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, Leung S, Roe R, Wiener C, Yu A (1997) Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51:553\u2013555. https:\/\/doi.org\/10.1038\/ki.1997.77","journal-title":"Kidney Int"},{"key":"7129_CR14","doi-asserted-by":"publisher","first-page":"584758","DOI":"10.1155\/2015\/584758","volume":"2015","author":"H Kumar","year":"2015","unstructured":"Kumar H, Choi DK (2015) Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway? Mediators Inflamm 2015:584758. https:\/\/doi.org\/10.1155\/2015\/584758","journal-title":"Mediators Inflamm"},{"key":"7129_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3181\/0902-RM-49","volume":"234","author":"E Konac","year":"2009","unstructured":"Konac E, Dogan I, Onen HI, Yurdakul AS, Ozturk C, Varol A, Ekmecki A (2009) Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer. Exp Biol Med (Maywood) 234:1109\u20131116. https:\/\/doi.org\/10.3181\/0902-RM-49","journal-title":"Exp Biol Med (Maywood)"},{"key":"7129_CR16","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.2174\/138161209789649420","volume":"15","author":"A G\u00f6rlach","year":"2009","unstructured":"G\u00f6rlach A (2009) Regulation of HIF-1alpha at the transcriptional level. Curr Pharm Des 15:3844\u20133852. https:\/\/doi.org\/10.2174\/138161209789649420","journal-title":"Curr Pharm Des"},{"key":"7129_CR17","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/carcin\/bgg132","volume":"24","author":"K Tanimoto","year":"2003","unstructured":"Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L, Nishiyama M (2003) Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24:1779\u20131783. https:\/\/doi.org\/10.1093\/carcin\/bgg132","journal-title":"Carcinogenesis"},{"key":"7129_CR18","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1210\/jc.2005-0991","volume":"90","author":"N Yamada","year":"2005","unstructured":"Yamada N, Horikawa Y, Oda N, Iizuka K, Shihara N, Kishi S, Takeda J (2005) Genetic variation in the hypoxia-inducible factor-1alpha gene is associated with type 2 diabetes in Japanese. J Clin Endocrinol Metab 90:5841\u20135847. https:\/\/doi.org\/10.1210\/jc.2005-0991","journal-title":"J Clin Endocrinol Metab"},{"key":"7129_CR19","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.47391\/JPMA.03-434","volume":"71","author":"U Zafar","year":"2021","unstructured":"Zafar U, Ali Z, Khaliq S, Lone K (2021) Association between hypoxia-inducible factor-1 alpha rs11549465 (1772 C>T) polymorphism and metabolic syndrome. J Pak Med Assoc 71:1832\u20131837. https:\/\/doi.org\/10.47391\/JPMA.03-434","journal-title":"J Pak Med Assoc"},{"key":"7129_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/15353702211055838","volume":"247","author":"Z Li","year":"2022","unstructured":"Li Z, Hu X, Wan J, Yang J, Jia Z, Tian L, Wu X, Song C, Yan C (2022) The alleles of AGT and HIF1A gene affect the risk of hypertension in plateau residents. Exp Biol Med (Maywood) 247:237\u2013245. https:\/\/doi.org\/10.1177\/15353702211055838","journal-title":"Exp Biol Med (Maywood)"},{"key":"7129_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.yexmp.2014.04.010","volume":"96","author":"A L\u00f3pez-Reyes","year":"2014","unstructured":"L\u00f3pez-Reyes A, Rodr\u00edguez-P\u00e9rez JM, Fern\u00e1ndez-Torres J, Mart\u00ednez-Rodr\u00edguez N, P\u00e9rez-Hern\u00e1ndez N, Fuentes-G\u00f3mez AJ et al (2014) The HIF1A rs2057482 polymorphism is associated with risk of developing premature coronary artery disease and with some metabolic and cardiovascular risk factors. The Genetics of Atherosclerotic Disease (GEA) Mexican Study. Exp Mol Pathol 96:405\u2013410. https:\/\/doi.org\/10.1016\/j.yexmp.2014.04.010","journal-title":"Exp Mol Pathol"},{"key":"7129_CR22","doi-asserted-by":"publisher","first-page":"e0119762","DOI":"10.1371\/journal.pone.0119762","volume":"10","author":"J Nanduri","year":"2015","unstructured":"Nanduri J, Vaddi DR, Khan SA, Wang N, Makarenko V, Semenza GL, Prabhakar NR (2015) HIF-1\u03b1 activation by intermittent hypoxia requires NADPH oxidase stimulation by xanthine oxidase. PLoS ONE 10:e0119762. https:\/\/doi.org\/10.1371\/journal.pone.0119762","journal-title":"PLoS ONE"},{"key":"7129_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G et al (2013) Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496:238\u2013242. https:\/\/doi.org\/10.1038\/nature11986","journal-title":"Nature"},{"key":"7129_CR24","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1073\/pnas.1620458114","volume":"114","author":"N Gupta","year":"2017","unstructured":"Gupta N, Sahu A, Prabhakar A, Chatterjee T, Tyagi T, Kumari B et al (2017) Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc Natl Acad Sci U S A 114:4763\u20134768. https:\/\/doi.org\/10.1073\/pnas.1620458114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7129_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","volume":"17","author":"TR Merriman","year":"2015","unstructured":"Merriman TR (2015) An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther 17:98. https:\/\/doi.org\/10.1186\/s13075-015-0609-2","journal-title":"Arthritis Res Ther"},{"key":"7129_CR26","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D et al (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74:1789\u20131798. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237","journal-title":"Ann Rheum Dis"},{"key":"7129_CR27","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinformatics"},{"key":"7129_CR28","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/bioinformatics\/btf869","volume":"19","author":"LW Hahn","year":"2003","unstructured":"Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376\u2013382. https:\/\/doi.org\/10.1093\/bioinformatics\/btf869","journal-title":"Bioinformatics"},{"key":"7129_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.6515\/ACS.201911_35(6).20190403B","volume":"35","author":"KH Huang","year":"2019","unstructured":"Huang KH, Tai CJ, Tsai YF, Kuan YH, Lee CY (2019) Correlation between Gout and Coronary Heart Disease in Taiwan: A Nationwide Population-Based Cohort Study. Acta Cardiol Sin 35:634\u2013640. https:\/\/doi.org\/10.6515\/ACS.201911_35(6).20190403B","journal-title":"Acta Cardiol Sin"},{"key":"7129_CR30","doi-asserted-by":"publisher","first-page":"e0273042","DOI":"10.1371\/journal.pone.0273042","volume":"17","author":"M Harun-Or-Roshid","year":"2022","unstructured":"Harun-Or-Roshid M, Ali MB, Jesmin MMNH (2022) Association of hypoxia inducible factor 1-Alpha gene polymorphisms with multiple disease risks: A comprehensive meta-analysis. PLoS ONE 17:e0273042. https:\/\/doi.org\/10.1371\/journal.pone.0273042","journal-title":"PLoS ONE"},{"key":"7129_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/gcc.22449","volume":"56","author":"I Gladek","year":"2017","unstructured":"Gladek I, Ferdin J, Horvat S, Calin GA, Kunej T (2017) HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies. Genes Chromosomes Cancer 56:439\u2013452. https:\/\/doi.org\/10.1002\/gcc.22449","journal-title":"Genes Chromosomes Cancer"},{"issue":"Pt 2","key":"7129_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2022.05.096","volume":"617","author":"L Huang","year":"2022","unstructured":"Huang L, He X, Peng W, He X, Xu B, Xu H, Wang Y, Xu W, Chen W, Wang S, Zhou L, Liu N, Xu Y, Lu W (2022) Hyperuricemia induces liver injury by upregulating HIF-1\u03b1 and inhibiting arginine biosynthesis pathway in mouse liver and human L02 hepatocytes. Biochem Biophys Res Commun 617(Pt 2):55\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.096","journal-title":"Biochem Biophys Res Commun"},{"key":"7129_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/ATVBAHA.119.313224","volume":"40","author":"Y Kimura","year":"2020","unstructured":"Kimura Y, Yanagida T, Onda A, Tsukui D, Hosoyamada M, Kono H (2020) Soluble Uric Acid Promotes Atherosclerosis via AMPK (AMP-Activated Protein Kinase)-Mediated Inflammation. Arterioscler Thromb Vasc Biol 40:570\u2013582. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313224","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"7129_CR34","doi-asserted-by":"publisher","first-page":"e52115","DOI":"10.7759\/cureus.52115","volume":"16","author":"P Khandwala","year":"2024","unstructured":"Khandwala P, Desai D, Sen M (2024) Obstructive Sleep Apnea: A Contributing Factor in Gout. Cureus 16(1):e52115. https:\/\/doi.org\/10.7759\/cureus.52115","journal-title":"Cureus"},{"key":"7129_CR35","first-page":"214","volume":"29","author":"S Deng","year":"2023","unstructured":"Deng S, Zhu T, Wang C, Gu X, Zhang J, Lu Q, Yang Y, Ma X (2023) Analysis of Correlation Between Serum Hypoxia-Inducible Factor-1\u03b1, Uric Acid, and Inflammatory Factor Levels and Lung Function in Patients with AECOPD. Altern Ther Health Med 29:214\u2013220","journal-title":"Altern Ther Health Med"},{"key":"7129_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/FPC.0000000000000314","volume":"28","author":"VM Rajagopal","year":"2018","unstructured":"Rajagopal VM, Rajkumar AP, Jacob KS, Jacob M (2018) Gene-gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia. Pharmacogenet Genomics 28:31\u201335. https:\/\/doi.org\/10.1097\/FPC.0000000000000314","journal-title":"Pharmacogenet Genomics"},{"key":"7129_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/03008207","volume":"60","author":"X Xu","year":"2019","unstructured":"Xu X, Liu X, Yang Y, He J, Gu H, Jiang M, Huang Y, Liu X, Liu L (2019) Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K\/Akt signaling pathways. Connect Tissue Res 60:571\u2013582. https:\/\/doi.org\/10.1080\/03008207","journal-title":"Connect Tissue Res"},{"key":"7129_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/jor.22859","volume":"33","author":"W Li","year":"2015","unstructured":"Li W, Cai L, Zhang Y, Cui L, Shen G (2015) Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2\u03b1. J Orthop Res 33:1061\u20131070. https:\/\/doi.org\/10.1002\/jor.22859","journal-title":"J Orthop Res"},{"key":"7129_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jacc.2023.10.030","volume":"83","author":"M Packer","year":"2024","unstructured":"Packer M (2024) Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol 83:371\u2013381. https:\/\/doi.org\/10.1016\/j.jacc.2023.10.030","journal-title":"J Am Coll Cardiol"},{"key":"7129_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/gucdd2020011","volume":"2","author":"RC Poulsen","year":"2024","unstructured":"Poulsen RC, Dalbeth N (2024) Circadian Rhythms in NLRP3 Inflammasome Regulation: Possible Implications for the Nighttime Risk of Gout Flares. Gout Urate Cryst Depos Dis 2:108\u2013132. https:\/\/doi.org\/10.3390\/gucdd2020011","journal-title":"Gout Urate Cryst Depos Dis"},{"key":"7129_CR41","doi-asserted-by":"publisher","first-page":"38703","DOI":"10.1074\/jbc.M111.275370","volume":"286","author":"JM Busillo","year":"2011","unstructured":"Busillo JM, Azzam KM, Cidlowski JA (2011) Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J Biol Chem 286:38703\u201338713. https:\/\/doi.org\/10.1074\/jbc.M111.275370","journal-title":"J Biol Chem"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07129-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07129-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T09:05:11Z","timestamp":1729242311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07129-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7129"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07129-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}